{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825894451401344.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/ki.1986.130"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0085253815337133?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0085253815337133?httpAccept=text/plain"}}],"dc:title":[{"@value":"Adult–onset minimal change nephrotic syndrome: A long–term follow–up"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825894451401345","@type":"Researcher","foaf:name":[{"@value":"Fernando Nolasco"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894451401349","@type":"Researcher","foaf:name":[{"@value":"J. Stewart Cameron"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894451401348","@type":"Researcher","foaf:name":[{"@value":"E.F. Heywood"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894451401347","@type":"Researcher","foaf:name":[{"@value":"Jackie Hicks"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894451401346","@type":"Researcher","foaf:name":[{"@value":"Chisholm Ogg"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894451401344","@type":"Researcher","foaf:name":[{"@value":"D. Gwyn Williams"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00852538"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00852538"}],"prism:publicationName":[{"@value":"Kidney International"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1986-06","prism:volume":"29","prism:number":"6","prism:startingPage":"1215","prism:endingPage":"1223"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0085253815337133?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0085253815337133?httpAccept=text/plain"}],"createdAt":"2007-05-31","modifiedAt":"2025-01-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360016862127247744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204868185984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Favorable Outcome of Low-dose Cyclosporine after Pulse Methylprednisolone in Japanese Adult Minimal-change Nephrotic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206446314240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Pathogenesis and Management of Minimal Change Nephrotic Syndrome"},{"@language":"ja","@value":"1．微小変化型ネフローゼ症候群"},{"@value":"微小変化型ネフローゼ症候群"},{"@language":"ja-Kana","@value":"ビショウ ヘンカガタ ネフローゼ ショウコウグン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679849347712","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Risedronate Therapy for the Prevention of Steroid-induced Osteoporosis in Patients with Minimal-change Nephrotic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679851737088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Enhanced Steroid Therapy in Adult Minimal Change Nephrotic Syndrome: A Systematic Review and Meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/2051714792004270080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease : a retrospective cohort study"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/ki.1986.130"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.54.3927_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"},{"@type":"CROSSREF","@value":"10.1007/s40620-022-01279-z_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"},{"@type":"CROSSREF","@value":"10.1007/s10157-013-0793-9_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.43.668_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"},{"@type":"CROSSREF","@value":"10.2169/naika.102.1105_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.49.3707_references_DOI_RQQ8AYEuRevMg9qw5DpOQkwGAFV"}]}